Literature DB >> 22264321

Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season.

D Viasus1, E Cordero, J Rodríguez-Baño, J A Oteo, A Fernández-Navarro, L Ortega, I Gracia-Ahufinger, M C Fariñas, E García-Almodovar, A Payeras, J R Paño-Pardo, E Muñez-Rubio, J Carratalà.   

Abstract

Although the influenza A (H1N1) 2009 virus is expected to circulate as a seasonal virus for some years after the pandemic period, its behaviour cannot be predicted. We analysed a prospective cohort study of hospitalized adults with influenza A (H1N1) 2009 pneumonia at 14 teaching hospitals in Spain to compare the epidemiology, clinical features and outcomes of influenza A (H1N1) 2009 pneumonia between the pandemic period and the first post-pandemic influenza season. A total of 348 patients were included: 234 during the pandemic period and 114 during the first post-pandemic influenza season. Patients during the post-pandemic period were older and more likely to have chronic obstructive pulmonary disease, chronic kidney disease and cancer than the others. Septic shock, altered mental status and respiratory failure on arrival at hospital were significantly more common during the post-pandemic period. Time from illness onset to receipt of antiviral therapy was also longer during this period. Early antiviral therapy was less frequently administered to patients during the post-pandemic period (22.9% versus 10.9%; p 0.009). In addition, length of stay was longer, and need for mechanical ventilation and intensive-care unit admission were significantly higher during the post-pandemic period. In-hospital mortality (5.1% versus 21.2%; p <0.001) was also greater during this period. In conclusion, significant epidemiological changes and an increased severity of influenza A (H1N1) 2009 pneumonia were found in the first post-pandemic influenza season. Physicians should consider influenza A (H1N1) 2009 when selecting microbiological testing and treatment in patients with pneumonia in the upcoming influenza season.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22264321     DOI: 10.1111/j.1469-0691.2011.03753.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  21 in total

Review 1.  Management of community-acquired pneumonia in older adults.

Authors:  Antonella F Simonetti; Diego Viasus; Carolina Garcia-Vidal; Jordi Carratalà
Journal:  Ther Adv Infect Dis       Date:  2014-02

2.  Comparable Disease Severity by Influenza Virus Subtype in the Acute Respiratory Infection Consortium Natural History Study.

Authors:  Christina Schofield; Rhonda E Colombo; Stephanie A Richard; Wei-Ju Chen; Mary P Fairchok; Ryan C Maves; John C Arnold; Patrick J Danaher; Robert G Deiss; Tahaniyat Lalani; Michael Rajnik; Eugene V Millar; Christian L Coles; Timothy H Burgess
Journal:  Mil Med       Date:  2020-08-14       Impact factor: 1.437

3.  Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity.

Authors:  Víctor H Borja-Aburto; Gerardo Chowell; Cécile Viboud; Lone Simonsen; Mark A Miller; Concepción Grajales-Muñiz; Cesar R González-Bonilla; Jose A Diaz-Quiñonez; Santiago Echevarría-Zuno
Journal:  Arch Med Res       Date:  2012-10-16       Impact factor: 2.235

4.  Nationwide surveillance of influenza during the pandemic (2009-10) and post-pandemic (2010-11) periods in Taiwan.

Authors:  Jen-Hsiang Chuang; Angela S Huang; Wan-Ting Huang; Ming-Tsan Liu; Jih-Haw Chou; Feng-Yee Chang; Wen-Ta Chiu
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

5.  Viral etiology of community-acquired pneumonia among adolescents and adults with mild or moderate severity and its relation to age and severity.

Authors:  Jiu-Xin Qu; Li Gu; Zeng-Hui Pu; Xiao-Min Yu; Ying-Mei Liu; Ran Li; Yi-Min Wang; Bin Cao; Chen Wang
Journal:  BMC Infect Dis       Date:  2015-02-22       Impact factor: 3.090

6.  Serological response of patients with influenza A (H1N1) pdm09-associated pneumonia: an observational study.

Authors:  Nasikarn Angkasekwinai; Bualan Kaewnapha; Duangdao Waywa; Peerawong Werarak; Sasima Tongsai; Kulkanya Chokephaibulkit; Visanu Thamlikitkul; Sontana Siritantikorn
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

7.  Changes in severity of influenza A(H1N1)pdm09 infection from pandemic to first postpandemic season, Germany.

Authors:  Nicola Lehners; Steffen Geis; Christoph Eisenbach; Kai Neben; Paul Schnitzler
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

8.  Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011.

Authors:  Katja Hoschler; Catherine Thompson; Nick Andrews; Monica Galiano; Richard Pebody; Joanna Ellis; Elaine Stanford; Marc Baguelin; Elizabeth Miller; Maria Zambon
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

9.  Epidemiological characterization of influenza A(H1N1)pdm09 cases from 2009 to 2010 in Baguio City, the Philippines.

Authors:  Rochelle R Pamaran; Taro Kamigaki; Teresita T Hewe; Korrine Madeleine C Flores; Edelwisa S Mercado; Portia P Alday; Alvin G Tan; Hitoshi Oshitani; Remigio M Olveda; Veronica L Tallo
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

10.  Influenza pneumonia among adolescents and adults: a concurrent comparison between influenza A (H1N1) pdm09 and A (H3N2) in the post-pandemic period.

Authors:  Shu Qiao Yang; Jiu Xin Qu; Chen Wang; Xiao Min Yu; Ying Mei Liu; Bin Cao
Journal:  Clin Respir J       Date:  2013-11-26       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.